Latest Stock Market News

As of 30-Jun-2023, promoters held 0.22 per cent stake in the company, while FIIs held 33.4 per cent and domestic institutional investors had 30.0 per cent.

The issue of RR Kabel has gained momentum on the final day of the bidding process with the overall subscription at 3.26 times. All the categories are fully subscribed, led by institutional investors (5.45x). The retail part was the least subscribed at 1.43x.

SoftBank took Arm private for $32 billion in 2016. Four years later, Nvidia offered to buy Arm in a stock and cash deal that was worth around $40 billion at the time. The offer was worth more than $80 billion at one point, thanks to a surge in Nvidia share prices, but the deal was scrapped early last year due to regulatory hurdles.

The stock traded at a P/E multiple of 80.02, while the price-to-book value ratio stood at 11.24.

​However, the pre-approved inspection has happened for one of the product where it will go to a big pharma para IV product and the supply will start immediately as soon as they want.

The company has 260 cumulative ANDA filings (including the recently acquired portfolio from Endo at Chestnut Ridge) with the USFDA, of which 230+ ANDAs have been approved. The company is eyeing around 60 new product launches over the next three years in the US.

The IPO comprises a fresh equity issue worth Rs 602 crore and an offer for sale (OFS) of up to 1.21 crore shares. The price band for the IPO is Rs 135-142, where investors can bid for a minimum of 105 equity shares and in multiples thereafter

The Relative Strength Index of the stock stood at 59.71 on Friday.

As of 30-Jun-2023, promoters held 0.0 per cent stake in the company, while FIIs held 12.45 per cent and domestic institutional investors had 5.57 per cent.